Industry News
Researchers activate drugs using infrared light
Scientists have successfully activated molecules located inside cell tissues using two-photon excitation from infrared light lasers, with an efficiency of almost 100%. [ + ]
Weaker antibodies make elders more susceptible to flu
The influenza vaccine may be less effective in the elderly because their B cells are less capable of producing antibodies that can adapt to protect against new viral strains. [ + ]
Don Whitley Scientific founder dies age 89
The directors of Don Whitley Scientific are sad to announce that the company's founder and chairman, Dr Don Whitley, has died at age 89 after a short illness. [ + ]
International research lab coming to Adelaide
A new international research laboratory, which aims to turbocharge scientific collaboration between Australia and France, is set to be established in Adelaide. [ + ]
Could subterranean microbes be found on Mars?
A robotic rover deployed in the most Mars-like environment on Earth, Chile's Atacama Desert, has recovered subsurface soil samples during a trial mission to find signs of life. [ + ]
Semi-identical twins identified during pregnancy
A boy and a girl in Brisbane have been confirmed as the second set of semi-identical twins in the world — and the first to be identified by doctors during pregnancy. [ + ]
Mapping the brain's immune system
A new map of the brain's immune system reveals that the phagocytes in the brain — the so-called microglia — all have the same core signature but adapt in different ways depending on their function. [ + ]
AusCann appoints global pharma executive as new CEO
The board of medicinal cannabis company AusCann has announced the appointment of Ido Kanyon as Chief Executive Officer, commencing 22 May. [ + ]
Positive trial results for peanut allergy therapy
Trial data showed that Melbourne biotech company Aravax's therapy has a highly favourable safety profile, even in patients with severe peanut allergies. [ + ]
Thermo Fisher Scientific to support BioNTech vaccine production
Thermo Fisher Scientific has signed a multiyear agreement with German immunotherapy company BioNTech, focused on supplying critical raw materials for the manufacturing of precise immunotherapy vaccine candidates. [ + ]
'Origami' diagnostic device for remote malaria detection
Researchers have revealed how origami-style folded paper, prepared with a printer and a hotplate, has detected malaria with 98% sensitivity in infected participants in Uganda. [ + ]
Antivirals cut liver cancer risk in Hep C patients
Direct-acting antivirals have been found to be associated with a reduced risk of liver cancer and death in people with chronic hepatitis C. [ + ]
$35m to fast-track rheumatic heart disease vaccine
The new funding will enable the manufacture and testing of a number of Strep A vaccines currently being developed and fast-tracking of clinical trials in Australia. [ + ]
Dementia patients lose the ability to daydream
Sufferers of frontotemporal dementia become increasingly fixed on their external environment and lose the ability to mind wander, even during periods of boredom. [ + ]
Minimally invasive lung cancer screening method
A new screening technique for non-small-cell lung cancer helps assess whether immune checkpoint inhibitors would be a suitable treatment method for individual patients. [ + ]
